Skip to main content

Idarucizumab Disease Interactions

There are 2 disease interactions with idarucizumab.

Moderate

Idarucizumab (applies to idarucizumab) fructose intolerance

Moderate Potential Hazard, Moderate plausibility.

The recommended dose of idarucizumab contains 4 g of sorbitol. Caution is advised when prescribing this agent to patients with hereditary fructose intolerance. Consider the combined daily metabolic load of sorbitol/fructose from all sources to avoid serious adverse reactions.

References (1)
  1. (2016) "Product Information. Praxbind (idarucizumab)." Boehringer Ingelheim
Moderate

Idarucizumab (applies to idarucizumab) liver impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

No formal studies of idarucizumab have been conducted in patients with hepatic impairment. Caution is advised.

References (1)
  1. (2016) "Product Information. Praxbind (idarucizumab)." Boehringer Ingelheim

Switch to consumer interaction data

Idarucizumab drug interactions

There are 5 drug interactions with idarucizumab.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.